[1] Palm W, de Lange T. How shelterin protects mammalian telomeres. Annu Rev Genet , 2008, 42: 301-334.
[2] O'Sullivan RJ, Karlseder J. Telomeres: protecting chromosomes against genome instability. Nat Rev Mol Cell Biol , 2010, 11(3): 171-181.
[3] Kabir S, Hockemeyer D, de Lange T. TALEN gene knockouts reveal no requirement for the conserved human shelterin protein Rap1 in telomere protection and length regulation. Cell Rep , 2014, 9(4): 1273-1280.
[4] Aeby E, Lingner J. ALT telomeres get together with nuclear receptors. Cell , 2015, 160(5): 811-813.
[5] Ly H. Genetic and environmental factors influencing human diseases with telomere dysfunction. Clin Exp Med , 2009, 2(2): 114-130.
[6] Fu D, Collins K. Purification of human telomerase complexes identifies factors involved in telomerase biogenesis and telomere length regulation. Mol Cell , 2007, 28(5): 773-785.
[7] Venteicher AS, Meng ZJ, Mason PJ, Veenstra TD, Artandi SE. Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly. Cell , 2008, 132(6): 945-957.
[8] Zhong F, Savage SA, Shkreli M, Giri N, Jessop L, Myers T, Chen R, Alter BP, Artandi SE. Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. Gene Dev , 2011, 25(1): 11-16.
[9] Trochet D, Mergui X, Ivkovic I, Porreca RM, Gerbault-Seureau M, Sidibe A, Richard F, Londono-Vallejo A, Perret M, Aujard F, Riou JF. Telomere regulation during ageing and tumorigenesis of the grey mouse lemur. Biochimie , 2015, 113: 100-110.
[10] Shay JW, Wright WE. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis , 2005, 26(5): 867-874.
[11] Killela PJ, Reitman ZJ, Jiao YC, Bettegowda C, Agrawal N, Diaz LA, Jr., Friedman AH, Friedman H, Gallia GL, Giovanella BC, Grollman AP, He TC, He YP, Hruban RH, Jallo GI, Mandahl N, Meeker AK, Mertens F, Netto GJ, Ahmed Rasheed B, Riggins GJ, Rosenquist TA, Schiffman M, Shih IM, Theodorescu D, Torbenson MS, Velculescu VE, Wang TL, Wentzensen N, Wood LD, Zhang M, McLendon RE, Bigner DD, Kinzler KW, Vogelstein B, Papadopoulos N, Yan H. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci USA , 2013, 110(15): 6021-6026.
[12] Horn S, Figl A, Sivaramakrishna Rachakonda P, Fischer C, Sucker A, Gast A, Kadel S, Moll I, Nagore E, Hemminki K, Schadendorf D, Kumar R. TERT promoter mutations in familial and sporadic melanoma. Science , 2013, 339(6122): 959-961.
[13] Kyo S, Takakura M, Fujiwara T, Inoue M. Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Cancer Sci , 2008, 99(8): 1528-1538.
[14] Greenberg RA. Telomeres, crisis and cancer. Curr Mol Med , 2005, 5(2): 213-218.
[15] Borah S, Xi LH, Zaug AJ, Powell NM, Dancik GM, Cohen SB, Costello JC, Theodorescu D, Cech TR. TERT promoter mutations and telomerase reactivation in urothelial cancer. Science , 2015, 347(6225): 1006-1010.
[16] Lacerte A, Korah J, Roy M, Yang XJ, Lemay S, Lebrun JJ. Transforming growth factor-β inhibits telomerase through SMAD3 and E2F transcription factors. Cell Signal , 2008, 20(1): 50-59.
[17] Ballal RD, Saha T, Fan SJ, Haddad BR, Rosen EM. BRCA1 localization to the telomere and its loss from the telomere in response to DNA damage. J Biol Chem , 2009, 284(52): 36083-36098.
[18] Zhu JY, Zhao YJ, Wang SW. Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene. Protein Cell , 2010, 1(1): 22-32.
[19] Wang SW, Hu CG, Zhu JY. Transcriptional silencing of a novel hTERT reporter locus during in vitro differentiation of mouse embryonic stem cells. Mol Biol Cell , 2007, 18(2): 669-677.
[20] Zhang ZX, Wang Y, Tao ZZ, Chen SM, Xiao BK, Zhou T. Subtelomeric demethylation deregulated hTERT expression, telomerase activity, and telomere length in four nasopharyngeal carcinoma cell lines. Cancer Biother Radiopharm , 2014, 29(7): 289-294.
[21] Atkinson SP, Hoare SF, Glasspool RM, Keith WN. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters. Cancer Res , 2005, 65(17): 7585-7590.
[22] Renaud S, Loukinov D, Bosman FT, Lobanenkov V, Benhattar J. CTCF binds the proximal exonic region of hTERT and inhibits its transcription. Nucleic Acids Res , 2005, 33(21): 6850-6860.
[23] Zhang Y, Chen LY, Han X, Xie W, Kim H, Yang D, Liu D, Zhou SY. Phosphorylation of TPP1 regulates cell cycle- dependent telomerase recruitment. Proc Natl Acad Sci US A , 2013, 110(14): 5457-5462.
[24] Kim JH, Park SM, Kang MR, Oh SY, Lee TH, Muller MT, Chung IK. Ubiquitin ligase MKRN1 modulates telomere length homeostasis through a proteolysis of hTERT. Gene Dev , 2005, 19(7): 776-781.
[25] Lee JH, Khadka P, Baek SH, Chung IK. CHIP promotes human telomerase reverse transcriptase degradation and negatively regulates telomerase activity. J Biol Chem , 2010, 285(53): 42033-42045.
[26] Cairney CJ, Keith WN. Telomerase redefined: integrated regulation of hTR and hTERT for telomere maintenance and telomerase activity. Biochimie , 2008, 90(1): 13-23.
[27] Kim NK, Theimer CA, Mitchell JR, Collins K, Feigon J. Effect of pseudouridylation on the structure and activity of the catalytically essential P6.1 hairpin in human telomerase RNA. Nucleic Acids Res , 2010, 38(19): 6746-6756.
[28] Collins K. Physiological assembly and activity of human telomerase complexes. Mech Ageing Dev , 2008, 129(1/2): 91-98.
[29] Wojtyla A, Gladych M, Rubis B. Human telomerase activity regulation. Mol Biol Rep , 2011, 38(5): 3339-3349.
[30] Tomlinson RL, Abreu EB, Ziegler T, Ly H, Counter CM, Terns RM, Terns MP. Telomerase reverse transcriptase is required for the localization of telomerase RNA to cajal bodies and telomeres in human cancer cells. Mol Biol Cell , 2008, 19(9): 3793-3800.
[31] Jády BE, Bertrand E, Kiss T. Human telomerase RNA and box H/ACA scaRNAs share a common Cajal body- specific localization signal. J Cell Biol , 2004, 164(5): 647-652.
[32] Li H. Unveiling substrate RNA binding to H/ACA RNPs: one side fits all. Curr Opin Struct Biol , 2008, 18(1): 78-85.
[33] Thomas Meier U. The many facets of H/ACA ribonucleoproteins. Chromosoma , 2005, 114(1): 1-14.
[34] Parry EM, Alder JK, Lee SS, Phillips JA, III, Loyd JE, Duggal P, Armanios M. Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita. J Med Genet , 2011, 48(5): 327-333.
[35] Hamma T, Reichow SL, Varani G, Ferré-D'Amaré AR. The Cbf5-Nop10 complex is a molecular bracket that organizes box H/ACA RNPs. Nat Struct Mol Biol , 2005, 12(12): 1101-1107.
[36] Venteicher AS, Abreu EB, Meng ZJ, McCann KE, Terns RM, Veenstra TD, Terns MP, Artandi SE. A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis. Science , 2009, 323(5914): 644-648.
[37] Tomlinson RL, Li J, Culp BR, Terns RM, Terns MP. A Cajal body-independent pathway for telomerase trafficking in mice. Exp Cell Res , 2010, 316(17): 2797-2809.
[38] Lin J, Jin R, Zhang B, Chen H, Bai YX, Yang PX, Han SW, Xie YH, Huang PT, Huang CF, Huang JJ. Nucleolar localization of TERT is unrelated to telomerase function in human cells. J Cell Sci , 2008, 121(Pt 13): 2169-2176.
[39] Wong JMY, Kyasa MJ, Hutchins L, Collins K. Telomerase RNA deficiency in peripheral blood mononuclear cells in X-linked dyskeratosis congenita. Hum Genet , 2004, 115(5): 448-455.
[40] Gallardo F, Chartrand P. Telomerase biogenesis: The long road before getting to the end. RNA Biol , 2008, 5(4): 212-215.
[41] Collins K. The biogenesis and regulation of telomerase holoenzymes. Nat Rev Mol Cell Bio , 2006, 7(7): 484-494.
[42] Grozdanov PN, Roy S, Kittur N, Thomas Meier U. SHQ1 is required prior to NAF1 for assembly of H/ACA small nucleolar and telomerase RNPs. RNA , 2009, 15(6): 1188-1197.
[43] Abreu E, Aritonovska E, Reichenbach P, Cristofari G, Culp B, Terns RM, Lingner J, Terns MP. TIN2-tethered TPP1 recruits human telomerase to telomeres in vivo . Mol Cell Biol , 2010, 30(12): 2971-2982.
[44] Cifuentes-Rojas C, Shippen DE. Telomerase regulation. Mutat Res , 2012, 730(1/2): 20-27.
[45] Cioce M, Lamond AI. Cajal bodies: a long history of discovery. Annu Rev Cell Dev Biol , 2005, 21: 105-131.
[46] Jády BE, Richard P, Bertrand E, Kiss T. Cell cycle-dependent recruitment of telomerase RNA and Cajal bodies to human telomeres. Mol Biol Cell , 2006, 17(2): 944-954.
[47] Tomlinson RL, Ziegler TD, Supakorndej T, Terns RM, Terns MP. Cell cycle-regulated trafficking of human telomerase to telomeres. Mol Biol Cell , 2006, 17(2): 955-965.
[48] Venteicher AS, Artandi SE. TCAB1: driving telomerase to Cajal bodies. Cell Cycle , 2009, 8(9): 1329-1331.
[49] Wang F, Podell ER, Zaug AJ, Yang YT, Baciu P, Cech TR, Lei M. The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature , 2007, 445(7127): 506-510.
[50] Xin HW, Liu D, Wan M, Safari A, Kim H, Sun W, O'Connor MS, Zhou SY. TPP1 is a homologue of ciliate TEBP-β and interacts with POT1 to recruit telomerase. Nature , 2007, 445(7127): 559-562.
[51] Shore D, Bianchi A. Telomere length regulation: coupling DNA end processing to feedback regulation of telomerase. EMBO J , 2009, 28(16): 2309-2322.
[52] Röth A, Harley CB, Baerlocher GM. Imetelstat (GRN163L)- telomerase-based cancer therapy. Recent Results Cancer Res , 2010, 184: 221-234.
[53] Chakraborty S, Ghosh U, Bhattacharyya NP, Bhattacharya RK, Roy M. Inhibition of telomerase activity and induction of apoptosis by curcumin in K-562 cells. Mutat Res , 2006, 596(1/2): 81-90.
[54] Mukherjee Nee Chakraborty S, Ghosh U, Bhattacharyya NP, Bhattacharya RK, Dey S, Roy M. Curcumin-induced apoptosis in human leukemia cell HL-60 is associated with inhibition of telomerase activity. Mol Cell Biochem , 2007, 297(1/2): 31-39.
[55] Lee JH, Chung IK. Curcumin inhibits nuclear localization of telomerase by dissociating the Hsp90 co-chaperone p23 from hTERT. Cancer Lett , 2010, 290(1): 76-86.
[56] Moon DO, Kang SH, Kim KC, Kim MO, Choi YH, Kim GY. Sulforaphane decreases viability and telomerase activity in hepatocellular carcinoma Hep3B cells through the reactive oxygen species-dependent pathway. Cancer Lett , 2010, 295(2): 260-266.
[57] Zhang XF, Tang WR, Luo Y. Aging or tumor: the crosstalk between telomerase and p53. Hereditas (Beijing) , 2009, 31(5): 451-456. 张秀峰, 唐文如, 罗瑛. 衰老或肿瘤: 端粒酶和p53的相互作用. 遗传, 2009, 31(5): 451-456.
|